Floatz logo

Alpha-Interferon

Melanoma (Skin)

MIPO ClinicPhase 3Dormant
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
81/ 100

Competitive context

152 Active assets in the Melanoma (Skin) cohort.

Asset / SponsorPhaseRating
Tyrosinase Peptide
University of Southern California
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
MIPO Clinic
Phase 3BBB
DACARBAZINE
Linnaeus Therapeutics, Inc.
Phase 3BBB
TIL
City of Hope Medical Center
Phase 2BBB
FILGRASTIM
Vastra Gotaland Region
Phase 3BB

View all 50 →

Same molecule, other indications

Alpha-Interferon is also rated in:

renal cell carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
kidney cancerDormant
BBB
Indicative ·
72 / 100
View asset →
melanomaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →